This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Financial Companies: Xanadu Quantum Technologies (XNDU), Crescent Capital BDC (CCAP) and Manulife Financial (MFC)

Tipranks - Tipranks - Sat May 16, 6:04AM CDT

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Xanadu Quantum Technologies (XNDU), Crescent Capital BDC (CCAP) and Manulife Financial (MFC).

Claim 55% Off TipRanks

Xanadu Quantum Technologies (XNDU)

In a report released today, Kingsley Crane from Canaccord Genuity reiterated a Buy rating on Xanadu Quantum Technologies, with a price target of $45.00. The company’s shares closed last Thursday at $15.13.

According to TipRanks.com, Crane is a 4-star analyst with an average return of 5.6% and a 46.0% success rate. Crane covers the Technology sector, focusing on stocks such as DigitalOcean Holdings, CrowdStrike Holdings, and Alarum Technologies. ;'>

Currently, the analyst consensus on Xanadu Quantum Technologies is a Moderate Buy with an average price target of $44.00.

See today’s best-performing stocks on TipRanks >>

Crescent Capital BDC (CCAP)

In a report released today, Finian O’Shea from Wells Fargo maintained a Hold rating on Crescent Capital BDC, with a price target of $12.00. The company’s shares closed last Thursday at $11.99.

According to TipRanks.com, O’Shea is a 4-star analyst with an average return of 6.1% and a 57.0% success rate. O’Shea covers the Financial sector, focusing on stocks such as MidCap Financial Investment Corporation, Nuveen Churchill Direct Lending Corp., and Morgan Stanley Direct Lending Fund. ;'>

Currently, the analyst consensus on Crescent Capital BDC is a Moderate Buy with an average price target of $14.13, a 17.6% upside from current levels. In a report released yesterday, Oppenheimer also downgraded the stock to Hold with a $16.00 price target.

Manulife Financial (MFC)

RBC Capital analyst Darko Mihelic maintained a Buy rating on Manulife Financial today and set a price target of $55.00. The company’s shares closed last Thursday at $37.54.

According to TipRanks.com, Mihelic is a 5-star analyst with an average return of 8.8% and a 63.2% success rate. Mihelic covers the Financial sector, focusing on stocks such as Canadian Bank of Commerce, National Bank of Canada, and Toronto Dominion Bank. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Manulife Financial with a $43.14 average price target, which is a 14.8% upside from current levels. In a report issued on May 1, TipRanks – OpenAI also upgraded the stock to Buy with a C$59.00 price target.

Read More on XNDU:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).